151 related articles for article (PubMed ID: 32096991)
1. Donepezil Inhibits Acetylcholinesterase via Multiple Binding Modes at Room Temperature.
Silva MA; Kiametis AS; Treptow W
J Chem Inf Model; 2020 Jul; 60(7):3463-3471. PubMed ID: 32096991
[TBL] [Abstract][Full Text] [Related]
2. Revealing the mechanistic pathway of cholinergic inhibition of Alzheimer's disease by donepezil: a metadynamics simulation study.
Ghosh S; Jana K; Ganguly B
Phys Chem Chem Phys; 2019 Jul; 21(25):13578-13589. PubMed ID: 31173012
[TBL] [Abstract][Full Text] [Related]
3. Discovery of a New Donepezil-like Acetylcholinesterase Inhibitor for Targeting Alzheimer's Disease: Computational Studies with Biological Validation.
Akhoon BA; Choudhary S; Tiwari H; Kumar A; Barik MR; Rathor L; Pandey R; Nargotra A
J Chem Inf Model; 2020 Oct; 60(10):4717-4729. PubMed ID: 32955256
[TBL] [Abstract][Full Text] [Related]
4. Discovery of Novel Acetylcholinesterase Inhibitors as Potential Candidates for the Treatment of Alzheimer's Disease.
Son M; Park C; Rampogu S; Zeb A; Lee KW
Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30823604
[TBL] [Abstract][Full Text] [Related]
5. New evidence for dual binding site inhibitors of acetylcholinesterase as improved drugs for treatment of Alzheimer's disease.
Zueva I; Dias J; Lushchekina S; Semenov V; Mukhamedyarov M; Pashirova T; Babaev V; Nachon F; Petrova N; Nurullin L; Zakharova L; Ilyin V; Masson P; Petrov K
Neuropharmacology; 2019 Sep; 155():131-141. PubMed ID: 31132435
[TBL] [Abstract][Full Text] [Related]
6. The inefficacy of donepezil on glycated-AChE inhibition: Binding affinity, complex stability and mechanism.
Yekta R; Sadeghi L; Dehghan G
Int J Biol Macromol; 2020 Oct; 160():35-46. PubMed ID: 32454110
[TBL] [Abstract][Full Text] [Related]
7. De-novo Drug Design, Molecular Docking and In-Silico Molecular Prediction of AChEI Analogues through CADD Approaches as Anti-Alzheimer's Agents.
Pandey S; Singh BK
Curr Comput Aided Drug Des; 2020; 16(1):54-72. PubMed ID: 30827255
[TBL] [Abstract][Full Text] [Related]
8. Phenoxyethyl Piperidine/Morpholine Derivatives as PAS and CAS Inhibitors of Cholinesterases: Insights for Future Drug Design.
Pourshojaei Y; Abiri A; Eskandari K; Haghighijoo Z; Edraki N; Asadipour A
Sci Rep; 2019 Dec; 9(1):19855. PubMed ID: 31882733
[TBL] [Abstract][Full Text] [Related]
9. 6-Methyluracil derivatives as acetylcholinesterase inhibitors for treatment of Alzheimer's disease.
Zueva IV; Semenov VE; Mukhamedyarov MA; Lushchekina SV; Kharlamova AD; Petukhova EO; Mikhailov AS; Podyachev SN; Saifina LF; Petrov KA; Minnekhanova OA; Zobov VV; Nikolsky EE; Masson P; Reznik VS
Int J Risk Saf Med; 2015; 27 Suppl 1():S69-71. PubMed ID: 26639718
[TBL] [Abstract][Full Text] [Related]
10. Roles of hybrid donepezil scaffolds as potent human acetylcholinesterase inhibitors using in silico interaction analysis, drug-likeness, and pharmacokinetics prediction.
Honorio P; Hannongbua S; Saparpakorn P
Chem Biol Interact; 2022 Dec; 368():110227. PubMed ID: 36302488
[TBL] [Abstract][Full Text] [Related]
11. Organoselenium Compounds as Acetylcholinesterase Inhibitors: Evidence and Mechanism of Mixed Inhibition.
Kumawat A; Raheem S; Ali F; Dar TA; Chakrabarty S; Rizvi MA
J Phys Chem B; 2021 Feb; 125(6):1531-1541. PubMed ID: 33538163
[TBL] [Abstract][Full Text] [Related]
12. Regional effects of donepezil and rivastigmine on cortical acetylcholinesterase activity in Alzheimer's disease.
Kaasinen V; Någren K; Järvenpää T; Roivainen A; Yu M; Oikonen V; Kurki T; Rinne JO
J Clin Psychopharmacol; 2002 Dec; 22(6):615-20. PubMed ID: 12454562
[TBL] [Abstract][Full Text] [Related]
13. Metal based donepezil analogues designed to inhibit human acetylcholinesterase for Alzheimer's disease.
Junaid M; Islam N; Hossain MK; Ullah MO; Halim MA
PLoS One; 2019; 14(2):e0211935. PubMed ID: 30785927
[TBL] [Abstract][Full Text] [Related]
14. The efficacy of donepezil administration on acetylcholinesterase activity and altered redox homeostasis in Alzheimer's disease.
Atukeren P; Cengiz M; Yavuzer H; Gelisgen R; Altunoglu E; Oner S; Erdenen F; Yuceakın D; Derici H; Cakatay U; Uzun H
Biomed Pharmacother; 2017 Jun; 90():786-795. PubMed ID: 28427041
[TBL] [Abstract][Full Text] [Related]
15. Competitive Inhibition Mechanism of Acetylcholinesterase without Catalytic Active Site Interaction: Study on Functionalized C
Liu Y; Yan B; Winkler DA; Fu J; Zhang A
ACS Appl Mater Interfaces; 2017 Jun; 9(22):18626-18638. PubMed ID: 28492309
[TBL] [Abstract][Full Text] [Related]
16. Productive reorientation of a bound oxime reactivator revealed in room temperature X-ray structures of native and VX-inhibited human acetylcholinesterase.
Gerlits O; Kong X; Cheng X; Wymore T; Blumenthal DK; Taylor P; Radić Z; Kovalevsky A
J Biol Chem; 2019 Jul; 294(27):10607-10618. PubMed ID: 31138650
[TBL] [Abstract][Full Text] [Related]
17. Rational design of carbamate-based dual binding site and central AChE inhibitors by a "biooxidisable" prodrug approach: Synthesis, in vitro evaluation and docking studies.
Ţînţaş ML; Gembus V; Alix F; Barré A; Coadou G; Truong L; Sebban M; Papamicaël C; Oulyadi H; Levacher V
Eur J Med Chem; 2018 Jul; 155():171-182. PubMed ID: 29886321
[TBL] [Abstract][Full Text] [Related]
18. Assessing the binding of cholinesterase inhibitors by docking and molecular dynamics studies.
Ali MR; Sadoqi M; Møller SG; Boutajangout A; Mezei M
J Mol Graph Model; 2017 Sep; 76():36-42. PubMed ID: 28711758
[TBL] [Abstract][Full Text] [Related]
19. A Systematic Review on Donepezil-based Derivatives as Potential Cholinesterase Inhibitors for Alzheimer's Disease.
Korabecny J; Spilovska K; Mezeiova E; Benek O; Juza R; Kaping D; Soukup O
Curr Med Chem; 2019; 26(30):5625-5648. PubMed ID: 29768996
[TBL] [Abstract][Full Text] [Related]
20. MARK4 Inhibited by AChE Inhibitors, Donepezil and Rivastigmine Tartrate: Insights into Alzheimer's Disease Therapy.
Shamsi A; Anwar S; Mohammad T; Alajmi MF; Hussain A; Rehman MT; Hasan GM; Islam A; Hassan MI
Biomolecules; 2020 May; 10(5):. PubMed ID: 32443670
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
